FDAnews
www.fdanews.com/articles/195829-aria-cv-nabs-breakthrough-device-status-for-pulmonary-hypertension-system

Aria CV Nabs Breakthrough Device Status for Pulmonary Hypertension System

February 10, 2020

Aria CV has gained a breakthrough device designation for its pulmonary hypertension system, a device that treats pulmonary arterial hypertension.

The implantable system helps to restore the health of arteries in the heart and lungs, reducing burden on the heart and improving blood flow.

Pulmonary arterial hypertension is a rare, progressive disorder that causes high blood pressure in the pulmonary arteries.

View today's stories